Unknown

Dataset Information

0

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.


ABSTRACT: BACKGROUND Long-term morbidity and mortality in liver transplant recipients is frequently secondary to immunosuppression toxicity. However, data are scarce regarding immunosuppression minimization in clinical practice. MATERIAL AND METHODS In this cross-sectional, multicenter study, we reviewed the indications of immunosuppression minimization (defined as tacrolimus levels below 5 ng/mL or cyclosporine levels below 50 ng/mL) among 661 liver transplant recipients, as well as associated factors and the effect on renal function. RESULTS Fifty-three percent of the patients received minimized immunosuppression. The median time from transplantation to minimization was 32 months. The most frequent indications were renal insufficiency (49%), cardiovascular risk (19%), de novo malignancy (8%), and cardiovascular disease (7%). The factors associated with minimization were older age at transplantation, longer post-transplant follow-up, pre-transplant diabetes mellitus and renal dysfunction, and the hospital where the patients were being followed. The patients who were minimized because of renal insufficiency had a significant improvement in renal function (decrease of the median serum creatinine level, from 1.50 to 1.34 mg/dL; P=0.004). Renal function significantly improved in patients minimized for other indications, too. In the long term, glomerular filtration rate significantly decreased in non-minimized patients and remained stable in minimized patients. CONCLUSIONS Immunosuppression minimization is frequently undertaken in long-term liver transplant recipients, mainly for renal insufficiency. Substantial variability exists regarding the use of IS minimization among centers.

SUBMITTER: Aguiar D 

PROVIDER: S-EPMC6248177 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


BACKGROUND Long-term morbidity and mortality in liver transplant recipients is frequently secondary to immunosuppression toxicity. However, data are scarce regarding immunosuppression minimization in clinical practice. MATERIAL AND METHODS In this cross-sectional, multicenter study, we reviewed the indications of immunosuppression minimization (defined as tacrolimus levels below 5 ng/mL or cyclosporine levels below 50 ng/mL) among 661 liver transplant recipients, as well as associated factors an  ...[more]

Similar Datasets

| S-EPMC7217743 | biostudies-literature
| S-EPMC7537191 | biostudies-literature
| S-EPMC11339048 | biostudies-literature
| S-EPMC8573720 | biostudies-literature
| S-EPMC4140547 | biostudies-literature
| S-EPMC5550760 | biostudies-other
| S-EPMC6482080 | biostudies-literature
| S-EPMC4560908 | biostudies-literature
| S-EPMC6482056 | biostudies-literature
| S-EPMC4946508 | biostudies-literature